Title | Description |
|---|---|
| Trial ID | KF5503/45 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3b |
| Brief title | Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability |
| Indication | Chronic Pain, nociceptive pain, neuropathic pain, low back pain |
| UTN | |
| CTG ID | NCT00986258 |
| CTIS ID (former EudraCT) | 2009-010428-25 |
| Trial status | Terminated |
| FPI | October 30, 2009 |
| LPO | January 21, 2011 |
| Countries | Belgium, Czechia, France, Germany, Netherlands, Poland, Spain, Switzerland |
| Gender | All |
| Age | >= 18 years of age |
| Results | Yes |
| Pubmed | 23475406 |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.